PortfoliosLab logoPortfoliosLab logo
SANA vs. RIVN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SANA vs. RIVN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sana Biotechnology, Inc. (SANA) and Rivian Automotive, Inc. (RIVN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SANA achieves a -17.69% return, which is significantly higher than RIVN's -24.45% return.


SANA

1D
-0.30%
1M
9.12%
YTD
-17.69%
6M
-26.05%
1Y
28.85%
3Y*
-16.29%
5Y*
-30.50%
10Y*

RIVN

1D
-1.39%
1M
4.71%
YTD
-24.45%
6M
-29.70%
1Y
9.08%
3Y*
3.24%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SANA vs. RIVN - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SANA
Sana Biotechnology, Inc.
-17.69%149.69%-60.05%3.29%-74.48%-27.80%
RIVN
Rivian Automotive, Inc.
-24.45%48.20%-43.31%27.29%-82.23%-2.87%

Correlation

The correlation between SANA and RIVN is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Nov 10, 2021

0.32

The correlation between SANA and RIVN shifts across timeframes, from 0.17 (1 year) to 0.32 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SANA:

$927.47M

RIVN:

$18.60B

EPS

SANA:

-$0.94

RIVN:

-$2.90

PB Ratio

SANA:

7.78

RIVN:

4.20

Total Revenue (TTM)

SANA:

$0.00

RIVN:

$5.53B

Gross Profit (TTM)

SANA:

$0.00

RIVN:

$57.00M

EBITDA (TTM)

SANA:

-$193.23M

RIVN:

-$3.18B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SANA vs. RIVN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SANA
SANA Risk / Return Rank: 5656
Overall Rank
SANA Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
SANA Sortino Ratio Rank: 6060
Sortino Ratio Rank
SANA Omega Ratio Rank: 5858
Omega Ratio Rank
SANA Calmar Ratio Rank: 5555
Calmar Ratio Rank
SANA Martin Ratio Rank: 5353
Martin Ratio Rank

RIVN
RIVN Risk / Return Rank: 4848
Overall Rank
RIVN Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
RIVN Sortino Ratio Rank: 5050
Sortino Ratio Rank
RIVN Omega Ratio Rank: 4848
Omega Ratio Rank
RIVN Calmar Ratio Rank: 4848
Calmar Ratio Rank
RIVN Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SANA vs. RIVN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sana Biotechnology, Inc. (SANA) and Rivian Automotive, Inc. (RIVN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SANARIVNDifference
Sharpe ratioReturn per unit of total volatility

+0.17

Sortino ratioReturn per unit of downside risk

+0.40

Omega ratioGain probability vs. loss probability

1.14

1.09

+0.06

Calmar ratioReturn relative to maximum drawdown

0.53

0.21

+0.31

Martin ratioReturn relative to average drawdown

0.85

0.41

+0.44

SANA vs. RIVN - Sharpe Ratio Comparison

The current SANA Sharpe Ratio is 0.31, which is higher than the RIVN Sharpe Ratio of 0.14. The chart below compares the historical Sharpe Ratios of SANA and RIVN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SANA vs. RIVN - Drawdown Comparison

The maximum SANA drawdown since its inception was -96.92%, roughly equal to the maximum RIVN drawdown of -95.12%. Use the drawdown chart below to compare losses from any high point for SANA and RIVN.


Loading charts...

Drawdown Indicators


SANARIVNDifference

Max Drawdown

Largest peak-to-trough decline

-96.92%

-95.12%

-1.80%

Max Drawdown (1Y)

Largest decline over 1 year

-54.73%

-42.54%

-12.19%

Max Drawdown (3Y)

Largest decline over 3 years

-88.11%

-69.61%

-18.50%

Max Drawdown (5Y)

Largest decline over 5 years

-94.82%

Current Drawdown

Current decline from peak

-92.30%

-91.34%

-0.96%

Average Drawdown

Average peak-to-trough decline

-81.52%

-86.35%

+4.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.10%

22.09%

+12.01%

Volatility

SANA vs. RIVN - Volatility Comparison

The current volatility for Sana Biotechnology, Inc. (SANA) is 19.66%, while Rivian Automotive, Inc. (RIVN) has a volatility of 23.17%. This indicates that SANA experiences smaller price fluctuations and is considered to be less risky than RIVN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SANARIVNDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.66%

23.17%

-3.51%

Volatility (6M)

Calculated over the trailing 6-month period

48.10%

46.83%

+1.27%

Volatility (1Y)

Calculated over the trailing 1-year period

94.68%

65.95%

+28.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

118.42%

77.49%

+40.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

116.90%

77.49%

+39.41%

Dividends

SANA vs. RIVN - Dividend Comparison

Neither SANA nor RIVN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SANA vs. RIVN - Financials Comparison

This section allows you to compare key financial metrics between Sana Biotechnology, Inc. and Rivian Automotive, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B202220232024202520260
1.38B
(SANA) Total Revenue
(RIVN) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SANA and RIVN have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RIVN has higher volatility (23.17%) compared to SANA (19.66%). In terms of maximum drawdown, SANA dropped -96.92% vs RIVN's -95.12%.

SANA currently has the higher Sharpe Ratio (0.31 vs 0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SANA and RIVN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer